Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients

Tabashnikova T.V.; Serova N.K.; Shimansky V.N.; Grigorieva N.N.

doi:https://doi.org/

Tabashnikova T.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Serova N.K.

NII neĭrokhirurgii im. N.N. Burdenko RAMN, Moskva

ORCID: 0000-0003-0148-7298

Shimansky V.N.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

ORCID: 0000-0002-9274-0254

Grigorieva N.N.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

ORCID: 0000-0001-8411-5152

Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients

Authors:

Tabashnikova T.V., Serova N.K., Shimansky V.N., Grigorieva N.N.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2012;76(4): 43‑48

Read: 1669 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tabashnikova TV, Serova NK, Shimansky VN, Grigorieva NN. Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients. Burdenko's Journal of Neurosurgery. 2012;76(4):43‑48. (In Russ.)

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Botulinum toxin type A injection in the middle and lower thirds of the face and neck area for aesthetic purposes. Plastic Surgery and Aesthetic Medicine. 2025;(3):108-117

Modern opportunities for correction of paralytic lagophthalmos. Plastic Surgery and Aesthetic Medicine. 2025;(3-2):50-55

Evaluation of the efficacy and safety of botulinum toxin type A injections for the prevention of aspiration complications in patients with neurogenic dysphagia and posterior sialorrhea of various etiologies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):126-133

Endoscopic diagnosis of neurogenic dysphagia and quantitative visual scale assessment of posterior sialorrhea for the prevention of aspiration events in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(4):119-119

The use of botulinum toxin type A in the conservative treatment of capsular contracture grades II—III according to Baker. P.A. Herzen Journal of Oncology. 2026;(3):50-55

Mucoperiosteal graft in the correction of paralytic lagophthalmos. Russian Annals of Ophthalmology. 2026;(3):5-12

Abstract:

The aim of our study was to assess the effectiveness of the ptosis induced by injection of Lantox (botulotoxin type A) into levator muscle projection in neurosurgical patients with lagophthalmos and trophic keratitis. The study included 66 patients at the age from 11 to 67 years. Lantox dose used was 10-25 U. Ptosis appeared after 1-7 days. Complete induced ptosis developed in 1-17 days and remained within 6-150 days. Full induced eyelid ptosis developed in 44 patients. Incomplete ptosis was observed in 19 patients. Drug resistance was seen in 3 patients. Our study results demonsrated effectiveness of the induced ptosis: complete recourse of trophic keratitis at development was seen in patients with complete drug-induced ptosis and significant decrease of trophic keratitis was observed in patients with semi-ptosis.

Keywords:

lagophthalmos

trophic keratitis

botulinum toxin type A

lantox

drug-induced eyelid ptosis

Authors:

Tabashnikova T.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Serova N.K.

NII neĭrokhirurgii im. N.N. Burdenko RAMN, Moskva

ORCID: 0000-0003-0148-7298

Shimansky V.N.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

ORCID: 0000-0002-9274-0254

Grigorieva N.N.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

ORCID: 0000-0001-8411-5152

Close metadata

References:

Artem'ev D.V., Orlova O.R., Morenkova A.E. Ispol'zovanie botoksa v meditsinskoi praktike. Nevrol zhurn 2000; 5: 4: 46-52.
Brzhevskii V.V. Osobennosti preparatov "iskusstvennoi slezy" v lechenii bol'nykh s razlichnymi klinicheskimi formami sindroma "sukhogo glaza". RMZh 2011; 12: 1: 38-40.
Grusha Ya.O., Ivanchenko Yu.F. Paralich litsevogo nerva: topograficheskie i patogeneticheskie osobennosti porazheniya. Vestn oftal'mol 2009; 3: 59-61.
Gusev E.I., Konovalov A.N., Burd G.S. Nevrologiya i neirokhirurgiya. M: Meditsina 2000; 146-156.
Putsillo M.V., Vinokurov A.G., Belov A.I. Neirokhirurgicheskaya anatomiya. M 2007; 2: 152-155.
Safonova T.N. Rol' funktsional'nykh metodov issledovaniya v diagnostike i lechenii sindroma sukhogo glaza. Vestn oftal'mol 2011; 3: 48-51.
Ellis M.F., Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis. Clin Exp Ophthalmol 2001; 29: 6: 394-399.
Gusek-Schneider G.C., Erbguth F. Protective ptosis by botulinum A toxin injection in corneal affectations. Klin Monbl Augenheilkd 1998; 213: 1: 15-22.
Merte R.L., Lanzl I.M. Botulinum toxin injection for production of ptosis. Ophthalmologe 2007; 104: 9: 767-770.
Naik M.N., Gangopadhyay N. et al. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye 2008; 22: 9: 1132-1136.
Norn M.S. Desiccation of the precorneal film. I. Corneal wetting-time. Acta Ophthalmol 1969; 47: 4: 865-880.
Prell J., Rampp S., Rachinger J. et al. Botulinum toxin for temporary corneal protection after surgery for vestibular schwannoma. J Neurosurg 2011; 114: 2: 426-431.